Susan A. Fineberg

Submitted by Anonymous (not verified) on
Full Name
Susan A. Fineberg
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/2851b8d0-d526-11eb-af57-a79c115e5bbd.jpg
Type
Provider
Faculty
First Name
Susan
Last Name
Fineberg
NPI
1942380449
Faculty ID
5173
Employment Status
part-time
Patient Type
Adult
Department
einstein-dept-pathology
Gender
Female
Email
sfineber@montefiore.org
Phone
718-920-4976
Titles
Type
Academic
Department
Department of Pathology
Department Link
Rank
Associate Professor
Type
Clinical
Title
Section Head Breast Pathology
Type
Clinical
Title
Attending Pathologist
Type
Clinical
Title
Associate Professor of Pathology
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798833 40.8799447)
Room
3
Address Line 1
Montefiore Medical Center
Address Line 3
111 East 210th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
SUNY Health Sciences at Stony Brook
Education Type Label
Fellowship
Education Institution
Memorial Sloan Kettering Cancer Center
Education Type Label
Residency
Education Institution
Bellevue Hospital
Research Areas
Breast cancer diagnosis with a focus on development of new histopathologic, immunohistochemical and genomic prognostic and predictive markers designed to optimize patient outcomes; investigation of the role of immunotherapy.
CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

Dr Fineberg's clinical focus is on the study of breast disease both neoplastic and benign.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Fineberg's research focus is on the development of new predictive and prognostic biomarkers to be used in breast cancer patients to optimize clinical outcomes, investigation of the role of immunotherapy and standardization of pathologic practices amongst breast pathologists.<quillbot-extension-portal></quillbot-extension-portal>

Selected Publications

<p>Lanjewar S, Patil P, <strong>Fineberg S. </strong>Pathologic reporting practices for breast cancer specimens after neoadjuvant chemotherapy- A survey of pathologists in academic institutions across the United States. Modern Pathol. 2019 .(33), 91-98. <a title="Read article" href="https://doi.org/10.1038/s41379-019-0326-5&quot; target="_blank">https://doi.org/10.1038/s41379-019-0326-5</a></p&gt;
<p>Kimberly J. Van Zee, MS, MD, Emily C. Zabor, MS, Rosemarie Di Donato, MD3, Bryan Harmon, MD, Jana Fox, MD, Monica Morrow, MD, Hiram S. Cody III, MD, <strong>Susan A. Fineberg, MD. </strong>A Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Vs Refined Oncotype DX Breast DCIS Score. Annals of Sugical Oncology . 2019 (26), 212-213. <a title="Read article" href="https://doi.org/10.1245/s10434-019-07537-4&quot; target="_blank">https://doi.org/10.1245/s10434-019-07537-4</a></p&gt;
<p>Didonato R, Shapiro N, Koenigsberg, D&acirc;&euro;&trade;Alfonso, T, Jaffer S, <strong>Fineberg S</strong>. Invasive Mucinous Carcinoma of the breast and Response Patterns After Neodjuvant Chemotherapy. Histopathology 2018 May; 72(6):965-973</p>
<p>Hazan, R, Suyamaa, K, Yao J, Liang H, Bernard , Loudig O Amgalm D, Mckimplson W, Phillops G, Segall J, Wang Y, <strong>Fineberg S,</strong> Norton L, Kitsis R. A paradoxical role for an Akt3 splice variant lacking serine 472 phosphorylation site in promoting apoptosis leading to suppression of mammary tumorigenesis. Cancer Research. 2018:78(1).103-114</p>
<p>Pearlman A, Upadhyay K, Cole K, Loke J, Suan K, <strong>Fineberg S,</strong> Freedland S, Shao Y, Ostrer H. Robust genomic copy number predictor of pan cancer metastasis. Genes and Cancer. 2018 <a title="Read article" href="https://doi.org/10.18632/genesandcancer.165&quot; target="_blank">https://doi.org/10.18632/genesandcancer.165</a></p&gt;
<p>Guo Tianhua, Shapiro Nella, Wang Yihong, <strong>Fineberg Susan</strong>. Pleomorphic lobular carcinoma in situ diagnosed by breast core biopsy: Clinicopathologic features and correlation with subsequent excision.Clinical Breast Cancer 2018 (4) e449-454 DOI: /10.1016/j.clbc.2017.10.004</p>
<p>Mclemore L Janakiram M, Albanese J, Shapiro N, Lo Y, Zang X, <strong>Fineberg S.</strong> An immunoscore using PD-L1, CD68 and tumor infiltrating lymphocytes (TILs) to predict response to neoadjuvant chemotherapy in invasive breast cancer. Appl Immunohistochem Mol Morphol.2018;26(9), 611-619. doi: 10.1097/PAI.0000000000000485</p>
<p>Maria-Vittoria Dieci, Nina Radosevic-Robin, <strong>Susan Fineberg</strong> et. al., on behalf of the International Immuno-Oncology Bio-marker Working Group* Update on Tumor Infiltrating Lymphocytes (TILs) in Breast Cancer, including recommendations to assess TILs in Residual Disease and DCIS: a report of the International Immuno-Oncology Biomarker Working group on Breast Cancer*. Seminars in Cancer Biology 2107:52.16-25. <a title="Persistent link using digital object identifier" href="https://doi.org/10.1016/j.semcancer.2017.10.003&quot; target="_blank">https://doi.org/10.1016/j.semcancer.2017.10.003</a></p&gt;
<p>Mantilla JG, Koenigsberg T, Reig B, Shapiro N, Villaneuva-Siles E, <strong>Fineberg S.</strong> Core biopsy of vascular neoplasms of the breast; Pathologic features , imaging and clinical findings. Amer J of Surg Pathol .2016; 40:1424-1434</p>
<p>Polley M, Leung S, Gao D, Mastropasqua M, Zabaglo L, Bartlett J, McShane L, Enos R, Badve S, Bane A, Borgquist S, <strong>Fineberg S</strong>, Lin M, Grabau A, Gutierrez C, Hugh J, Moriya T, Ohi Y, Osborne K, Penault-Llorca F, Piper T, Porter P, Sakatani T, Salgado R, Starczynski J, L&Atilde;&brvbar;nkholm A, Viale G, Dowsett M, Hayes D, Nielsen T, on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (BIG-NABCG). An international study to increase concordance in Ki67 scoring. Modern Pathology .2015; 28 (6) :778. PubMed [citation] PMID 25698062</p>
<p>Diaz J, Stead L, Shapiro N, Newell R, Loudig O, Lo Y, Sparano J, <strong>Fineberg S</strong>. Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease. Breast Cancer Research and Treatment. 2013; 138 :91-97. PubMed [citation] PMID 23417359</p>
<p>Giricz, O, Reynolds P, Rammuauth A, Liu C, Wang T, Stead L, Childs G, Rohan T, Shapiro, N <strong>, Fineberg S,</strong> Kenny P, Loudig O. Has-miR375 is differentially expressed during lobular neoplasia and promotes loss of mammary acinar polarity. Journal of Pathology. 2012; 226 (1): 108-119 .PubMed [citation] PMID 21953071</p>
<p>Auerbach J, Kim M, <strong>Fineberg S</strong>. Can results of routine pathologic evaluation of lymph node-negative estrogen receptor-positive stage I or II invasive breast cancer be used to predict the Oncotype DX Assay Recurrence Score result? Archives of Pathology and Laboratory Medicine. 2010; 134, (11): 1697-1701. PubMed [citation] PMID 21043825</p>
<p>Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, deng HF, Ament PS, <strong>Fineberg S,</strong> Pestell RG, Carasco N. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nature Medicine .2000; 6 (8): 871-878. PubMed [citation] PMID: 10932223</p>
<p>Casey M, Zimmerman J, Rosenblatt R, <strong>Fineberg S.</strong> Mastectomy without malignancy following carcinoma diagnosed by large core stereotactic breast biopsy. Modern Pathology.1997; 10 (12): 1209-1213. PubMed [citation] PMID: 9436965</p>
<p><strong>Fineberg S</strong>, Rosen P. Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma. Am J Clin Pathol. 1994; 102 (6): 757-762. PubMed [citation] PMID: 7801888</p>

EMR ID
3791
Biography

<p>Susan Fineberg, MD, is an Attending Pathologist, Section Head Breast Pathology and Associate Professor, Pathology at Montefiore Einstein. An integral member of the multidisciplinary breast program leadership team, Dr. Fineberg&rsquo;s clinical focus is the study of tissue to diagnose breast disease, both neoplastic and benign.</p><p>After receiving her Bachelor of Arts in chemistry from State University of New York (SUNY) Binghamton in 1983, Dr. Fineberg pursued her medical degree at SUNY Stonybrook School of Medicine, earning her Doctor of Medicine in 1987. She completed her anatomic and clinical pathology residency training at New York University Medical Center in 1992, followed by an oncologic surgical pathology fellowship at Memorial Sloan Kettering Cancer Center in 1993.</p><p>Dr. Fineberg's research focus includes biomarker development in invasive breast cancer, particularly in the neoadjuvant setting, prognostic and predictive markers for ductal carcinoma in situ progression and recurrence, the role of immune response in breast cancer progression, and standardization of practice among breast pathologists. She has over 60 peer-reviewed publications on breast disease, has authored book chapters on the subject and has presented her work at national meetings.</p><p>Dr. Fineberg is board certified and is an active member of many national and international pathology organizations including the United States and Canadian Academy of Pathology, the International Society of Breast Disease and the International TILs Immuno-Oncology Biomarker Working Group for Breast Cancer.</p>

Is Open Scheduling
Off

Sheldon M. Feldman

Submitted by Anonymous (not verified) on
Full Name
Sheldon M. Feldman
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/8b39c6a0-c3d2-11eb-9ea2-7374238588d1.jpg
Type
Provider
Faculty
Expert
First Name
Sheldon
Last Name
Feldman
NPI
1942283742
Faculty ID
8553
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-surgery
Gender
Male
Email
sfeldman@montefiore.org
Phone
718-862-8845
Titles
Type
Academic
Department
Department of Surgery
Rank
Professor
Type
Clinical
Title
Chief, Division of Breast Surgery & Breast Surgical Oncology
Tags
me-patientcare-cancer-research-therapeutics
me-patientcare-surgery-generalsurgery
Type
Clinical
Title
Director, Breast Cancer Services
Type
Clinical
Title
Professor, Department of Surgery
Type
Clinical
Type
Administrative
Locations
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.91189 40.82636)
Address Line 1
951 Brook Avenue
City
Bronx
State
NY
Zip
10451
Location Title
Brook Avenue at 951 Breast Surgery
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8463934 40.8452984)
Room
212
Address Line 1
Montefiore Medical Park
Address Line 2
1521 Jarrett Place
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Fellowship
Education Institution
Newark Beth Israel Medical Center
Education Type Label
Residency
Education Institution
NYU Medical Center
Specialties
Expert Tags
Areas of Expertise
New surgical and minimally invasive breast cancer treatments
Lymphedema expert
Skin-sparing and nipple-preserving mastectomies
Clinical trials focused on the application of ductoscopy for the imaging, diagnosis and treatment of patients with ductal carcinoma, the most common type of breast cancer
Expert Summary

<p>Dr. Feldman leads the breast surgery and breast surgical oncology program at Montefiore. Since 2003, he has been recognized annually as one of New York Metro Area's "Top Doctors" and since 2004, he has also been included in the annual "Guide to America's Top Surgeons."

Dr. Feldman is a recognized leader in the development of innovative minimally invasive techniques to diagnose breast cancer. He also leads extensive research into the causes of breast cancer with the goal of being able to diagnose earlier and more effectively.</p>

CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

<p>The development of innovative, minimally invasive techniques to diagnose breast cancer.</p>

Research Focus

<p>Dr. Feldman has led extensive research into the causes of breast cancer with the goal of being able to diagnose earlier and more effectively.</p>

EMR ID
21947
Biography

<p>Sheldon Marc Feldman, MD, is Chief, Breast Surgery and Breast Surgical Oncology, Professor, Surgery and Director, Breast Cancer Services at Montefiore Einstein. His clinical focus includes breast cancer, oncoplastic surgery with an emphasis on optimizing breast conservation, nipple-sparing mastectomy, minimally invasive diagnosis and treatment, intraoperative radiation, targeted tumor ablation, lymphedema prevention, and complementary integrative holistic care with an emphasis on physician-patient communication.</p><p>In 1971, Dr. Feldman received his Bachelor of Science in Biology and Psychology from State University of New York at Stony Brook. Following this, he attended the New York University Medical School where he received his Doctor of Medicine in 1975. He began his postgraduate training at NYU Medical Center, Bellevue Hospital in 1975 and spent 5 years completing an internship and residency in Surgery. He became Executive Chief Surgical Resident in 1980. Dr. Feldman then trained at Newark Beth Israel Medical Center, where he completed a fellowship in Peripheral Vascular Surgery in 1981.</p><p>Extending his clinical focus, Dr. Feldman focuses his research on targeted tumor ablation, intraoperative margin assessment, novel surgical techniques to minimize lymphedema risk, intraductal approach to breast cancer&ndash;evaluating biomarkers in nipple aspirate fluid (NAF) and intraductal diagnosis and therapy, nonsurgical treatment of ductal carcinoma, and breast cancer prevention. He has been a principal investigator on multiple research projects and has given lectures both nationally and internationally. Dr. Feldman&rsquo;s work has been presented in over 100 peer-reviewed publications.</p><p>From 2008 to 2015, he was named a New York Super Doctor in the New York Times. He was President of the American Society of Breast Surgeons from 2016 to 2017, and he is currently president of the New York Metropolitan Breast Group.</p><p>Dr. Feldman is board certified by the American Board of Surgery, and he is a fellow of the American College of Surgeons. He is also a member of numerous professional societies, including the American Society of Breast Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology and the International Society of Lymphology.</p>

Is Open Scheduling
Off
Subscribe to Intraductal Papilloma